bpc-157 clinical studies humans Frontiers BPC 157: Speed Up Healing
Description
The presence of almost abrogated thrombosis, arterial and venous, peripherally and centrally, may signify reactivated blood flow
The typical research protocol escalates doses: Notice how the units per dose climb as the dose escalates
No clinical safety profile for BPC-157 or PDA in humans has been established through completed Phase 1 trials
Ces symptmes sont gnralement transitoires et cessent l'arrt de la supplmentation
[36:03] Andrew Huberman Yeah
